Literature DB >> 11967822

The renin-angiotensin-aldosterone system is suppressed in adults with Type 1 diabetes.

M Bojestig1, F H Nystrom, H J Arnqvist, J Ludvigsson, B E Karlberg.   

Abstract

Poor glycaemic control and high blood pressure are two important risk factors for the development of retinopathy and nephropathy in Type 1 diabetes. The renin-angiotensin-aldosterone system (RAAS) may be involved in this process, since treatment with angiotensin-converting enzyme (ACE) inhibitors postpones the development of these complications. We investigated whether plasma renin activity (PRA), plasma angiotensin II (Ang II) and atrial natriuretic peptide (ANP) differed in Type 1 diabetic patients compared with healthy controls. We recruited 80 patients with Type 1 diabetes of more than 10 years' duration and 75 age-matched controls. We found that PRA and Ang II concentrations were significantly lower in patients than in the controls. The levels of ANP, on the other hand, were higher in patients than in controls. PRA correlated negatively to the mean value of HbA(1c) during the previous five years. PRA and Ang II were significantly lower in patients with mean HbA(1c) >8.4% compared with those with mean HbA(1c) <7.2%. In summary, we found patients with Type 1 diabetes to have RAAS suppression and increased ANP levels, suggesting a state of fluid retention.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11967822     DOI: 10.3317/jraas.2000.065

Source DB:  PubMed          Journal:  J Renin Angiotensin Aldosterone Syst        ISSN: 1470-3203            Impact factor:   1.636


  6 in total

Review 1.  Hyporeninemic hypoaldosteronism and diabetes mellitus: Pathophysiology assumptions, clinical aspects and implications for management.

Authors:  André Gustavo P Sousa; João Victor de Sousa Cabral; William Batah El-Feghaly; Luísa Silva de Sousa; Adriana Bezerra Nunes
Journal:  World J Diabetes       Date:  2016-03-10

2.  Effect of renal tubule-specific knockdown of the Na+/H+ exchanger NHE3 in Akita diabetic mice.

Authors:  Akira Onishi; Yiling Fu; Manjula Darshi; Maria Crespo-Masip; Winnie Huang; Panai Song; Rohit Patel; Young Chul Kim; Josselin Nespoux; Brent Freeman; Manoocher Soleimani; Scott Thomson; Kumar Sharma; Volker Vallon
Journal:  Am J Physiol Renal Physiol       Date:  2019-06-05

Review 3.  Urinary serine proteases and activation of ENaC in kidney--implications for physiological renal salt handling and hypertensive disorders with albuminuria.

Authors:  Per Svenningsen; Henrik Andersen; Lise H Nielsen; Boye L Jensen
Journal:  Pflugers Arch       Date:  2014-12-09       Impact factor: 3.657

Review 4.  The nephrotic syndrome: pathogenesis and treatment of edema formation and secondary complications.

Authors:  Melissa A Cadnapaphornchai; Oleksandra Tkachenko; Dmitry Shchekochikhin; Robert W Schrier
Journal:  Pediatr Nephrol       Date:  2013-08-30       Impact factor: 3.714

Review 5.  The renin-angiotensin system and diabetes: an update.

Authors:  Antônio Ribeiro-Oliveira; Anelise Impeliziere Nogueira; Regina Maria Pereira; Walkiria Wingester Vilas Boas; Robson Augusto Souza Dos Santos; Ana Cristina Simões e Silva
Journal:  Vasc Health Risk Manag       Date:  2008

Review 6.  Therapeutic Renin Inhibition in Diabetic Nephropathy-A Review of the Physiological Evidence.

Authors:  Bianca Domingues Massolini; Stephanie San Gregorio Contieri; Giulia Severini Lazarini; Paula Antoun Bellacosa; Mirela Dobre; Georg Petroianu; Andrei Brateanu; Luciana Aparecida Campos; Ovidiu Constantin Baltatu
Journal:  Front Physiol       Date:  2020-03-12       Impact factor: 4.566

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.